Stanford University
Showing 901-950 of 1,923 Results
-
Gloria S. Kim
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Current Research and Scholarly InterestsAsian Health
Medical education
Health services delivery
Management of chronic disease
Patient and physician satisfaction -
Grace S. Kim, MD
Assistant Professor of Otolaryngology - Head & Neck Surgery (OHNS)
BioGrace S. Kim, MD is a pediatric otolaryngologist and surgeon-scientist in the Department of Otolaryngology–Head & Neck Surgery at Stanford University. Her clinical practice focuses on the full spectrum of pediatric otolaryngology, with particular expertise in hearing loss, chronic ear disease, thyroid disorders, vascular malformations and pediatric head and neck conditions. Her research investigates the immune mechanisms underlying congenital hearing loss and inner ear injury, with the goal of developing therapies to preserve hearing in children.
Dr. Kim received her BA in Biochemical Sciences from Harvard University and her MD from Stanford University School of Medicine, where she also completed an additional year of research as a Howard Hughes Medical Institute Research Fellow. She completed residency training in otolaryngology–head and neck surgery at Stanford, including a two-year NIH-sponsored research fellowship investigating vestibular repair and regeneration, followed by fellowship training in complex pediatric otolaryngology at Stanford.
Dr. Kim joined the Stanford faculty in 2023. She leads a translational research program investigating inner ear neuroimmunology and congenital hearing loss, using animal models to understand how congenital cytomegalovirus infection and immune responses impact the developing auditory system. Her long-term goal is to develop targeted therapies that prevent hearing loss in children. Her work is supported by an NIH Mentored Clinical Scientist Research Career Development (K08) Award, as well as funding from the American Society of Pediatric Otolaryngology and the Stanford Maternal & Child Health Research Institute. -
Hyeonji Kim
Visiting Instructor/Lecturer, Ophthalmology
BioDr. Kim is a translational bioprinting researcher specializing in tissue engineering and ocular regenerative medicine. She holds a Ph.D. in Mechanical Engineering. Her research focuses on developing innovative therapeutic platforms for ocular diseases using 3D bioprinting, biomanufacturing, and regenerative medicine.
She has developed 3D-bioprinted corneal stromal constructs that replicate native collagen alignment and achieve transparency, successfully restoring visual function in preclinical beagle models and subsequent veterinary clinical applications. She also advanced a simplified in situ corneal therapy that has completed veterinary clinical trials and is now licensed for anticipated human trials. Currently, she is developing ocular therapeutic implants using advanced 3D printing approaches.
Dr. Kim has collaborated with regulatory authorities and preclinical evaluation agencies to define guidelines for 3D-printed combination medical devices and to conduct safety testing of bioprinted corneas. Her work has been internationally recognized, contributing to her university's ranking as 12th in Reuters’ 2019 “Top 100 Most Innovative Universities,” and spans drug delivery, diagnostic and therapeutic devices, personalized medicine, and translational ophthalmology. Her long-term vision is to engineer personalized therapeutic implants and biofabrication technologies that bridge fundamental science and clinical translation, initially focusing on restoring vision and ultimately expanding to regenerative therapies for multiple organ systems. -
Hyunjin Kim
Licensing Manager, Life Sciences, Office of Technology Licensing (OTL)
BioHyunjin is a Licensing Manager at Stanford Office of Technology Licensing. Hyunjin holds a PhD in Biochemistry from the University of Illinois at Chicago. With a strong foundation in life sciences, Hyunjin joined Aspire Capital as a biotech analyst intern where she gained valuable experience in analyzing and assessing biotech companies with clinical stage assets. After the internship, Hyunjin joined the Office of Technology Management at University of Illinois at Chicago where she managed various intellectual properties. At Stanford, Hyunjin is responsible for managing life science portfolios.
-
Jackson Kim, MD
Clinical Assistant Professor, Medicine - Nephrology
BioDr. Kim is a Clinical Assistant Professor in the Division of Nephrology at Stanford Health Care.
Dr. Kim diagnoses and treats a range of conditions affecting the kidneys, including glomerulonephritis, nephrotic syndrome, chronic kidney disease, and genetic kidney disease. He creates a customized, comprehensive treatment plan for every patient he serves.
Dr. Kim has a keen research interest in glomerular kidney disease, particularly glomerulonephritis. He has authored manuscripts, conducted case studies, and published his work in several peer-reviewed journals. -
Jane P. Kim
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Kim’s research focuses on applying statistical approaches to evaluate and improve digital interventions, and using empirical approaches to understand ethical considerations for AI applications in healthcare.
-
Jeewon Sylvia Kim
Program Manager, SPARK at Stanford
Current Role at StanfordProgram manager for SPARK Translational Science Program overseeing educational seminar series, managing projects and facilitating SPARK global operations.
-
Jiyeong Kim
Postdoctoral Scholar, Dermatology
BioDr. Jiyeong Kim is a post-doctoral scholar at the Stanford Center for Digital Health and the Department of Dermatology School of Medicine. As a multi-disciplined data scientist, Dr. Kim applies artificial intelligence (AI) to clinical informatics, harnessing patient-generated health information and data to enhance patient-centered care, which could be tailored to each patient group for improving patient engagement and better health outcomes. In her work, Dr. Kim leverages large language models, machine learning, and natural language processing to understand patients' and caregivers' genuine voices of care needs and needed support for individuals with chronic diseases, not limited to diabetes, cardiovascular disease, and cancer.
Research Interest
-LLMs and Generative AI to Listen to the Patient
-Generative AI-Assisted Enhanced Patient Care
-ML-based Disease Prediction Modeling
-Patient-Generated Data and Precision Health -
Johanna Kim
Executive Director, AIMI, Rad/Integrative Biomedical Imaging Informatics at Stanford
BioJohanna specializes in launching and leading world-class research programs. At Stanford AIMI, she plays a pivotal role in the development and design of all programs, particularly focusing on research and education programs, funding opportunities, and major events. Her leadership extends to shaping partnership programs, fundraising, and enhancing AIMI's outreach strategies. Skilled in building strong teams and fostering interdisciplinary collaborations, Johanna adeptly navigates the complexities of the academic and healthcare sectors. Her strategic support has been invaluable in advancing technology development, securing substantial research funding, and elevating the impact of publications. Johanna’s 20-year career is marked by her commitment to transforming healthcare through innovative technology.
